×

Hope and Progress: New Evidence That Millions More Cancer Patients May Now Benefit from Revolutionary Immunotherapy Drugs

The percentage of cancer patients eligible for so-called "checkpoint inhibitors" has soared more than 40 percent since 2011

Published May 6, 2019